Grant

MRC Developmental Pathway Funding Scheme

MRC scheme funding translational development of therapeutics, devices and diagnostics from late discovery through to early-phase clinical testing.

Quick answer

The Developmental Pathway Funding Scheme (DPFS) supports translational research that develops new therapeutics, devices, diagnostics and interventions from late discovery to early clinical testing. Funding is awarded through UK research organisations on a structured pathway with milestone reviews. Applications follow MRC's standard translational research process.

Funding amount

Varies

Region

United Kingdom

Stage

Any stage

Provider

Medical Research Council

Eligibility

UK research organisations and their partners with a defined translational project meeting MRC's scope and milestone criteria.

Industries

Editorial status: Standard Listing— accurate programme summary; not fully advisor-reviewed.

Source: https://www.ukri.org/opportunity/developmental-pathway-funding-scheme/

Last editorial review: 6/14/2026

Last data check: 6/14/2026

Conservative note: Standard listing. Scheme scope and budgets are updated periodically — confirm current DPFS guidance with MRC.

FundingAtlas is independent. Always verify details on the official scheme page before applying.